Compound details
Bryonioside E
| Compound ID | CDAMM01713 |
|---|---|
| Common name | Bryonioside E | IUPAC name | 17-[3,5-dihydroxy-6-methyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-3-hydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one |
| Molecular formula | C36H60O10 |
| Retention time | 14.08 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 653.429 | Theoretical mz | 653.426 |
| Error | 3.56 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.9287 |
| Inchi key | XNVPZHUWJCSREL-FCJHLEICNA-N |
|---|---|
| Smiles | O=C1CC2(C)C(CCC2(C)C3CC=C4C(CCC(O)C4(C)C)C13C)C(C)C(O)CC(O)C(OC5OC(CO)C(O)C(O)C5O)(C)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|